TRAVERE THERAPEUTICS INC TVTX 深 滬
等待開盤 09-06 09:30:00 美东时间
21.64
+0.490
+2.32%
華盛通- 最 高22.24
- 今 開21.36
- 成交量 385.07万股
- 最 低 21.1869
- 昨 收 21.15
- 總市值 19.29亿
- 52周最高 25.29
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 12.91
- 委 比 44.70%
- 總股本 8913.87万
- 歷史最高 37.04
- 量 比 1.36
- 振 幅 4.98%
- 歷史最低 0.90
- 每 手 1
- 風險率 2.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Travere Therapeutics (TVTX) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Travere The...
09-03 22:55
Deep Dive Into Travere Therapeutics Stock: Analyst Perspectives (6 Ratings)
6 analysts have shared their evaluations of Travere Therapeutics (NASDAQ:TVTX) ...
08-28 20:00
Travere Therapeutics Announces FDA Eases FILSPARI Liver Monitoring From Monthly To Every 3 Months, Removes Embryo-Fetal Toxicity REMS Requirement
FDA simplifies liver monitoring schedule from monthly to every three months for the duration of treatment and removes embryo-fetal toxicity REMS monitoringTravere Therapeutics, Inc., (NASDAQ:TVTX) today announced that
08-28 05:10
Viking Global Dumps UnitedHealth, Loads Up On Disney, McDonald's, JPMorgan, AMD In Q2 Shake-Up
Andreas Halvorsen's Viking Global adjusted its stock portfolio in Q2, cutting healthcare exposure and adding consumer brands, industrials, and tech.
08-15 20:17
Travere Therapeutics Earnings Call Highlights FILSPARI Success
Travere Therapeutics, Inc. (($TVTX)) has held its Q2 earnings call. Read on for...
08-08 08:25
Wedbush Maintains Outperform on Travere Therapeutics, Raises Price Target to $32
Wedbush analyst Laura Chico maintains Travere Therapeutics (NASDAQ:TVTX) with a Outperform and raises the price target from $30 to $32.
08-07 20:38
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
Earnings Preview: Travere Therapeutics
Travere Therapeutics (NASDAQ:TVTX) is gearing up to announce its quarterly earn...
08-06 03:10
Demystifying Travere Therapeutics: Insights From 8 Analyst Reviews
During the last three months, 8 analysts shared their evaluations of Travere Th...
07-02 05:01
单日暴涨130%+，肾病领域再成行业焦点
转自：新康界 4月30日，诺华公司宣布以17亿美元收购美股上市医药公司Regulus(NASDAQ:RGLS)，受此消息影响，Regulus的股价...
06-23 19:50
